Placenta
Volume 31, Issue 4 , Pages 295-304 , April 2010

Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction

  • L.S. Loubière

      Affiliations

    • School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK
    • Joint first authors.
    • ,
  • E. Vasilopoulou

      Affiliations

    • School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK
    • Joint first authors.
    • ,
  • J.N. Bulmer

      Affiliations

    • Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
    • ,
  • P.M. Taylor

      Affiliations

    • Division of Molecular Physiology, University of Dundee, Dundee, UK
    • ,
  • B. Stieger

      Affiliations

    • Division of Clinical Pharmacology and Toxicology, University Hospital of Zurich, Zürich, Switzerland
    • ,
  • F. Verrey

      Affiliations

    • Institute of Physiology and Center for Integrative Human Physiology, University of Zürich, Switzerland
    • ,
  • C.J. McCabe

      Affiliations

    • School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK
    • ,
  • J.A. Franklyn

      Affiliations

    • School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK
    • ,
  • M.D. Kilby

      Affiliations

    • School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK
    • ,
  • S.-Y. Chan

      Affiliations

    • School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK
    • Corresponding Author InformationCorresponding author. School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, Level 3, Birmingham Women's Hospital Foundation Trust, Metchley Park Road, Edgbaston, Birmingham, B15 2TG, UK.

,Accepted 22 January 2010.

References 

  1. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341:549–555
  2. Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL, de Vijlder JJ. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol. 2003;59:282–288
  3. de Escobar GM, Obregon MJ, del Rey FE. Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab. 2004;18:225–248
  4. Chan S, Kachilele S, McCabe CJ, Tannahill LA, Boelaert K, Gittoes NJ, et al. Early expression of thyroid hormone deiodinases and receptors in human fetal cerebral cortex. Brain Res Dev Brain Res. 2002;138:109–116
  5. Chan S, Franklyn JA, Kilby M. Maternal thyroid hormones and fetal brain development. Curr Opin Endocrinol Diabetes. 2005;12:23–30
  6. Calvo RM, Jauniaux E, Gulbis B, Asuncion M, Gervy C, Contempre B, et al. Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab. 2002;87:1768–1777
  7. Costa A, Arisio R, Benedetto C, Bertino E, Fabris C, Giraudi G, et al. Thyroid hormones in tissues from human embryos and fetuses. J Endocrinol Invest. 1991;14:559–568
  8. Vulsma T, Gons MH, de Vijlder JJ. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med. 1989;321:13–16
  9. Kilby MD, Verhaeg J, Gittoes N, Somerset DA, Clark PM, Franklyn JA. Circulating thyroid hormone concentrations and placental thyroid hormone receptor expression in normal human pregnancy and pregnancy complicated by intrauterine growth restriction (IUGR). J Clin Endocrinol Metab. 1998;83:2964–2971
  10. Barber KJ, Franklyn JA, McCabe CJ, Khanim FL, Bulmer JN, Whitley GS, et al. The in vitro effects of triiodothyronine on epidermal growth factor-induced trophoblast function. J Clin Endocrinol Metab. 2005;90:1655–1661
  11. Maruo T, Matsuo H, Mochizuki M. Thyroid hormone as a biological amplifier of differentiated trophoblast function in early pregnancy. Acta Endocrinol. 1991;125:58–66
  12. Oki N, Matsuo H, Nakago S, Murakoshi H, Laoag-Fernandez JB, Maruo T. Effects of 3,5,3′-triiodothyronine on the invasive potential and the expression of integrins and matrix metalloproteinases in cultured early placental extravillous trophoblasts. J Clin Endocrinol Metab. 2004;89:5213–5221
  13. LaFranchi SH, Haddow JE, Hollowell JG. Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes?. Thyroid. 2005;15:60–71
  14. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12:63–68
  15. Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005;105:239–245
  16. Visser WE, Friesema EC, Jansen J, Visser TJ. Thyroid hormone transport in and out of cells. Trends Endocrinol Metab. 2008;19:50–56
  17. Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet. 2004;74:168–175
  18. Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, Reeser M, et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet. 2004;364:1435–1437
  19. Schwartz CE, May MM, Carpenter NJ, Rogers RC, Martin J, Bialer MG, et al. Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am J Hum Genet. 2005;77:41–53
  20. Heuer H, Maier MK, Iden S, Mittag J, Friesema EC, Visser TJ, et al. The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology. 2005;146:1701–1706
  21. Chan SY, Franklyn JA, Pemberton HN, Bulmer JN, Visser TJ, McCabe CJ, et al. Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction. J Endocrinol. 2006;189:465–471
  22. Park SY, Kim J-K, Kim IJ, Choi BK, Jung KY, Lee S, et al. Reabsorption of neutral amino acids mediated by amino acid transporter LAT2 and TAT1 in the basolateral membrane of proximal tubule. Arch Pharm Res. 2005;28:421–432
  23. Patel P, Weerasekera N, Hitchins M, Boyd CA, Johnston DG, Williamson C. Semi quantitative expression analysis of MDR3, FIC1, BSEP, OATP-A, OATP-C, OATP-D, OATP-E and NTCP gene transcripts in 1st and 3rd trimester human placenta. Placenta. 2003;24:39–44
  24. Pineda M, Fernandez E, Torrents D, Estevez R, Lopez C, Camps M, et al. Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biol Chem. 1999;274:19738–19744
  25. Ritchie JW, Taylor PM. Role of the system L permease LAT1 in amino acid and iodothyronine transport in placenta. Biochem J. 2001;356:719–725
  26. Sato K, Sugawara J, Sato T, Mizutamari H, Suzuki T, Ito A, et al. Expression of organic anion transporting polypeptide E (OATP-E) in human placenta. Placenta. 2003;24:144–148
  27. Khong TY. Pathology of intrauterine growth retardation. Am J Reprod Immunol. 1989;21:132–136
  28. Fattal-Valevski A, Leitner Y, Kutai M, Tal-Posener E, Tomer A, Lieberman D, et al. Neurodevelopmental outcome in children with intrauterine growth retardation: a 3-year follow-up. J Child Neurol. 1999;14:724–727
  29. Larroque B, Bertrais S, Czernichow P, Leger J. School difficulties in 20-year-olds who were born small for gestational age at term in a regional cohort study. Pediatrics. 2001;108:111–115
  30. Kilby MD, Barber K, Hobbs E, Franklyn JA. Thyroid hormone action in the placenta. Placenta. 2005;26:105–113
  31. Thorpe-Beeston JG, Nicolaides KH, Snijders RJ, Felton CV, McGregor AM. Thyroid function in small for gestational age fetuses. Obstet Gynecol. 1991;77:701–706
  32. Chan S, Kachilele S, Hobbs E, Bulmer JN, Boelaert K, McCabe CJ, et al. Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies. J Clin Endocrinol Metab. 2003;88:4488–4495
  33. Robson SC, Simpson H, Ball E, Lyall F, Bulmer JN. Punch biopsy of the human placental bed. Am J Obstet Gynecol. 2002;187:1349–1355
  34. Ramadan T, Camargo SM, Summa V, Hunziker P, Chesnov S, Pos KM, et al. Basolateral aromatic amino acid transporter TAT1 (Slc16a10) functions as an efflux pathway. J Cell Physiol. 2006;206:771–779
  35. Huber RD, Gao B, Sidler Pfandler MA, Zhang-Fu W, Leuthold S, Hagenbuch B, et al. Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain. Am J Physiol Cell Physiol. 2007;292:C795–C806
  36. James SR, Franklyn JA, Reaves BJ, Smith VE, Chan SY, Barrett TG, et al. Monocarboxylate transporter 8 in neuronal cell growth. Endocrinology. 2009;150:1961–1969
  37. Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A, Meier PJ. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood–brain barrier. J Pharmacol Exp Ther. 2000;294:73–79
  38. Kullak-Ublick GA, Glasa J, Boker C, Oswald M, Grutzner U, Hagenbuch B, et al. Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas. Gastroenterology. 1997;113:1295–1305
  39. Ayuk PT, Sibley CP, Donnai P, D'Souza S, Glazier JD. Development and polarization of cationic amino acid transporters and regulators in the human placenta. Am J Physiol Cell Physiol. 2000;278:C1162–C1171
  40. Okamoto Y, Sakata M, Ogura K, Yamamoto T, Yamaguchi M, Tasaka K, et al. Expression and regulation of 4F2hc and hLAT1 in human trophoblasts. Am J Physiol Cell Physiol. 2002;282:C196–C204
  41. Hoeltzli SD, Smith CH. Alanine transport systems in isolated basal plasma membrane of human placenta. Am J Physiol. 1989;256:C630–C637
  42. Lewis RM, Glazier J, Greenwood SL, Bennett EJ, Godfrey KM, Jackson AA, et al. l-Serine uptake by human placental microvillous membrane vesicles. Placenta. 2007;28:445–452
  43. Laoag-Fernandez JB, Matsuo H, Murakoshi H, Hamada AL, Tsang BK, Maruo T. 3,5,3′-Triiodothyronine down-regulates Fas and Fas ligand expression and suppresses caspase-3 and poly (adenosine 5′-diphosphate-ribose) polymerase cleavage and apoptosis in early placental extravillous trophoblasts in vitro. J Clin Endocrinol Metab. 2004;89:4069–4077
  44. Benirschke K, Kaufmann P, Baergen RN. Architecture of normal villous trees. In: Pathology of the human placenta. 4th ed. Springer Verlag; 2000;p.116 [Chapter 7]
  45. Hume R, Simpson J, Delahunty C, van Toor H, Wu SY, Williams FL, et al. Human fetal and cord serum thyroid hormones: developmental trends and interrelationships. J Clin Endocrinol Metab. 2004;89:4097–4103
  46. Fisher DA. Fetal thyroid function: diagnosis and management of fetal thyroid disorders. Clin Obstet Gynecol. 1997;40:16–31
  47. Herrero E, Diez-Guerra J, Aragon MC, Valdivieso F, Gimenez C. Developmental studies on the uptake of tyrosine by synaptosomes and plasma membrane vesicles derived from rat brain. Effect of thyroid hormones. Int J Dev Neurosci. 1986;4:13–20
  48. Capelo LP, Beber EH, Fonseca TL, Gouveia CH. The monocarboxylate transporter 8 and L-type amino acid transporters 1 and 2 are expressed in mouse skeletons and in osteoblastic MC3T3-E1 cells. Thyroid. 2009;19:171–180
  49. Zlender V, Breljak D, Ljubojevic M, Flajs D, Balen D, Brzica H, et al. Low doses of ochratoxin A upregulate the protein expression of organic anion transporters Oat1, Oat2, Oat3 and Oat5 in rat kidney cortex. Toxicol Appl Pharmacol. 2009;239:284–296
  50. Jansson T, Scholtbach V, Powell TL. Placental transport of leucine and lysine is reduced in intrauterine growth restriction. Pediatr Res. 1998;44:532–537
  51. Roos S, Jansson N, Palmberg I, Saljo K, Powell TL, Jansson T. Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth. J Physiol. 2007;582:449–459
  52. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem. 2003;278:40128–40135
  53. Kim DK, Kanai Y, Matsuo H, Kim JY, Chairoungdua A, Kobayashi Y, et al. The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location. Genomics. 2002;79:95–103
  54. Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ. Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol. 2008;22:1357–1369
  55. Friesema EC, Docter R, Moerings EP, Verrey F, Krenning EP, Hennemann G, et al. Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinology. 2001;142:4339–4348
  56. Hagenbuch B. Cellular entry of thyroid hormones by organic anion transporting polypeptides. Best Pract Res Clin Endocrinol Metab. 2007;21:209–221
  57. Hagenbuch B, Meier PJ. The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta. 2003;1609:1–18
  58. Fujiwara K, Adachi H, Nishio T, Unno M, Tokui T, Okabe M, et al. Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner. Endocrinology. 2001;142:2005–2012
  59. Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, et al. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001;120:525–533

PII: S0143-4004(10)00039-1

doi: 10.1016/j.placenta.2010.01.013

Placenta
Volume 31, Issue 4 , Pages 295-304 , April 2010

Article Tools

* Image Usage & Resolution